FOXO3 and gastric cancer: Taken together, above results indicated that PLOD3 exerted its drug-resistance promoting capacity via inducing FoxO3 protein degradation, which resulted in abundant Survivin expression, and led to Trastuzumab resistance formation in GC cells.